A predictive scoring system for therapy-failure in persons with chronic myeloid leukemia receiving initial imatinib therapy.
第一作者:
Xiao-Shuai,Zhang
第一单位:
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);人类(Humans);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);白血病, 髓样, 慢性期(Leukemia, Myeloid, Chronic-Phase);蛋白激酶抑制剂(Protein Kinase Inhibitors);治疗结果(Treatment Outcome)
DOI
10.1038/s41375-022-01527-y
PMID
35194158
发布时间
2022-11-09
- 浏览0

Leukemia
1336-1342页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文